Evaluation of two decellularization methods in the development of a whole-organ decellularized rat liver scaffold

Liver International

Volumn 33, Issue 3, 2013, Pages 448-458

  Ren, Haozhen ^a,b   Shi, Xiaolei ^a,b   Tao, Liang ^a   Xiao, Jiangqiang ^a   Han, Bing ^a,b   Zhang, Yue ^a   Yuan, Xianwen ^a,b   Ding, Yitao ^a,b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b Jiangsu Province's Key Medical Center for Hepatobiliary Disease   (China)

Author keywords

Decellularization; Extracellular matrix; Hepatocyte; Liver; Tissue engineering

Indexed keywords

ALBUMIN; AMMONIA; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGEN TYPE 5; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2C11; CYTOCHROME P450 3A1; DODECYL SULFATE SODIUM; ELASTIN; FIBRONECTIN; GLYCOSAMINOGLYCAN; MESSENGER RNA; SCATTER FACTOR; TISSUE SCAFFOLD; TRITON X 100; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOARTIFICIAL LIVER; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOFLUORESCENCE TEST; LIVER; LIVER CELL; LIVER CELL CULTURE; LIVER DECELLULARIZATION; LIVER DEVELOPMENT; LIVER FUNCTION; LIVER REGENERATION; LIVER STRUCTURE; MALE; NONHUMAN; PROTEIN SECRETION; RAT; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; UREA CYCLE;

ANIMALS; COLLAGEN; ELASTIN; END STAGE LIVER DISEASE; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; LIVER; OCTOXYNOL; RATS; REGENERATIVE MEDICINE; SODIUM DODECYL SULFATE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84873746988     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12088     Document Type: Article

References (25)

1. Klein AS, Messersmith EE, Ratner LE, et al. Organ donation and utilization in the United States. Am J Transplant 2010; 10: 973-986.
2. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751.
3. Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 2002; 295: 1009-1014.
4. Kulig KM, Vacanti JP. Hepatic tissue engineering. Transpl Immunol 2004; 12: 303-310.
5. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23: 47-55.
6. Dahl SL, Koh J, Prabhakar V, Niklason LE. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003; 12: 659-666.
7. Badylak SF, Lantz GC, Coffey A, Geddes LA. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 1989; 47: 74-80.
8. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater 2009; 5: 1-13.
9. Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010; 16: 814-820.
10. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006; 27: 3675-3683.
11. Baptista PM, Siddiqui MM, Lozier G, et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011; 53: 604-617.
12. Wang Y, Cui CB, Yamauchi M, et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 2011; 53: 293-305.
13. Soto-Gutierrez A, Zhang L, Medberry C, et al. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods 2011; 17: 677-686.
14. Shupe T, Williams M, Brown A, Willenberg B, Petersen BE. Method for the decellularization of intact rat liver. Organogenesis 2010; 6: 134-136.
15. Grant RA. Estimation of hydroxyproline by the autoanalyser. J Clin Pathol 1964; 17: 685-686.
16. 2+ on enzymatic dispersion of isolated, perfused liver. Exp Cell Res 1972; 74: 450-454.
17. Sellaro TL, Ravindra AK, Stolz DB, Badylak SF. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng 2007; 13: 2301-2310.
18. Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 2006; 12: 519-526.
19. Brown BN, Barnes CA, Kasick RT, et al. Surface characterization of extracellular matrix scaffolds. Biomaterials 2010; 31: 428-437.
20. Liao J, Joyce EM, Sacks MS. Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials 2008; 29: 1065-1074.
21. De Kock J, Ceelen L, De Spiegelaere W, et al. Simple and quick method for whole-liver decellularization: a novel in vitro three-dimensional bioengineering tool? Arch Toxicol 2011; 85: 607-612.
22. Zhou P, Lessa N, Estrada DC, et al. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transpl 2011; 17: 418-427.
23. Yeung BKS, Chong PYC, Petillo PA. Synthesis of glycosaminoglycans. In: Wang PG, Bertozzi CR, eds. Glycochemistry. New York: Marcel Dekker., 2001: 425.
24. Mertens G, Cassiman JJ, Van den Berghe H, Vermylen J, David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells Core protein characterization and antithrombin III binding properties. J Biol Chem 1992; 267: 20435-20443.
25. Hubbell JA. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 2003; 14: 551-558.